Cargando…

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

Detalles Bibliográficos
Autores principales:	Singh, Manjari, Paul, Manash K., Roy, Subhadeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482239/ https://www.ncbi.nlm.nih.gov/pubmed/37681032 http://dx.doi.org/10.3389/fonc.2023.1265523

Ejemplares similares

Role of hypoxia in the tumor microenvironment and targeted therapy
por: Chen, Gaoqi, et al.
Publicado: (2022)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival
por: Singh, Lakhveer, et al.
Publicado: (2023)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Editorial: Novel Targets and Targeting Technologies to Modulate Tumor Microenvironment
por: Prakash, Jai, et al.
Publicado: (2016)

Hypoxia in Breast Cancer—Scientific Translation to Therapeutic and Diagnostic Clinical Applications
por: Zhang, Ying, et al.
Publicado: (2021)

Editorial: Proteoglycans in the Tumor Microenvironment
por: Brunetti, Jlenia, et al.
Publicado: (2022)

Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells?
por: Gastelum, Gilberto, et al.
Publicado: (2021)

Chemical activation of prolyl hydroxylase-2 by BBAP-1 down regulates hypoxia inducible factor-1α and fatty acid synthase for mammary gland chemoprevention
por: Singh, Manjari, et al.
Publicado: (2018)

Editorial: Combinatorial Approaches for Cancer Treatment: From Basic to Translational Research
por: Cerrato, Aniello, et al.
Publicado: (2022)

Editorial: Megakaryocytes as regulators of tumor microenvironments
por: Migliaccio, Anna Rita, et al.
Publicado: (2022)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

Editorial: Tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics
por: Xu, Yiming, et al.
Publicado: (2023)

Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signalling
por: Singh, Manjari, et al.
Publicado: (2019)

Editorial: Tumor Microenvironment and Resistance to Current Therapies
por: Lasfar, Ahmed, et al.
Publicado: (2019)

Editorial: The effects of chemotherapy towards the tumor microenvironment
por: Abu, Nadiah, et al.
Publicado: (2022)

Editorial: Impact of tumor microenvironment on lung cancer
por: Levantini, Elena
Publicado: (2023)

Editorial: Tumor microenvironment in primary brain cancers
por: Niechi, Ignacio, et al.
Publicado: (2023)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Editorial: Plasticity of immune cells in tumor microenvironment
por: Oksenych, Valentyn
Publicado: (2023)

Conducive target range of breast cancer: Hypoxic tumor microenvironment
por: Cheng, Wen, et al.
Publicado: (2022)

Editorial: New Approaches to Breast Cancer Radiotherapy
por: Jacobson, Geraldine Meerbott, et al.
Publicado: (2021)

Correction: Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signalling
por: Singh, Manjari, et al.
Publicado: (2022)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Editorial: Exploring the breast tumor microenvironment: Association to metastasis, novel risk factors and novel treatments and immunotherapies
por: Nava-Castro, Karen Elizabeth, et al.
Publicado: (2022)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Editorial: Tumor microenvironment signaling networks in pathophysiology and therapeutics
por: Pirini, Francesca, et al.
Publicado: (2022)

Editorial: The interconnection between epigenetic modifications and the tumor microenvironment
por: He, Siyuan, et al.
Publicado: (2023)

Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies
por: Wobus, Manja, et al.
Publicado: (2023)

Editorial: GBM stem cells and the brain tumor microenvironment
por: Li, Yunqing, et al.
Publicado: (2023)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
por: Tolba, Mai F., et al.
Publicado: (2021)

Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
por: Li, Yue, et al.
Publicado: (2021)

Regulation of Transactivation at C-TAD Domain of HIF-1α by Factor-Inhibiting HIF-1α (FIH-1): A Potential Target for Therapeutic Intervention in Cancer
por: Rani, Soniya, et al.
Publicado: (2022)

Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells
por: Yousefnia, Saghar, et al.
Publicado: (2020)

Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast Cancer
por: Sun, Xiaoli, et al.
Publicado: (2021)

Editorial: Tumor Hypoxia: Impact in Tumorigenesis, Diagnosis, Prognosis, and Therapeutics
por: Gomez, Christian R.
Publicado: (2016)

Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
por: Kondoh, Hiroshi, et al.
Publicado: (2021)

Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
por: Behren, Andreas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_52012lnd5tufor44uao0dvm07s